Litigation Details for Astellas Pharma Inc. v. Xellia Pharmaceuticals ApS (D. Del. 2018)
✉ Email this page to a colleague
Astellas Pharma Inc. v. Xellia Pharmaceuticals ApS (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-11-18 |
Court | District Court, D. Delaware | Date Terminated | 2019-04-29 |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | None | Referred To | |
Patents | 6,774,104 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Astellas Pharma Inc. v. Xellia Pharmaceuticals ApS
Details for Astellas Pharma Inc. v. Xellia Pharmaceuticals ApS (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-11-18 | 1 | an action for patent infringement of United States Patent No. 6,774,104 (“the ’104 patent”), arising under…Unenforceability, and/or Non-infringement for U.S. Patent No. 6,774,104 Pursuant to Section 505(j)(2)(B)(iv) of … The ’104 Patent 20. The PTO duly and legally issued the ’104 patent, entitled “Stabilized…copy of the ’104 patent is attached as Exhibit A. 21. The ’104 patent claims, inter alia…assignee of the ’104 patent. 29. AUS is the exclusive licensee of the ’104 patent with the rights | External link to document | |
2019-04-30 | 14 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,104 B1. (Attachments: #…2018 29 April 2019 1:18-cv-01818 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2018-11-18 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,104 B1. (lak) (Entered:…2018 29 April 2019 1:18-cv-01818 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |